Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q1 FY24 results · Apr–Jun 2023
Krishna Institute of Medical Sciences reported revenue from operations of ₹606.03 crore (up 22.3% from Q1 FY23) and net profit of ₹86.67 crore (up 9.4% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 606.03 | 495.51 | +22.3% | 575.93 | +5.2% |
| Other income | 3.11 | 5.33 | −41.7% | 4.88 | −36.3% |
| Total income | 609.14 | 500.85 | +21.6% | 580.81 | +4.9% |
| Profit before tax | 118.58 | 107.36 | +10.5% | 127.27 | −6.8% |
| Net profit for the period | 86.67 | 79.25 | +9.4% | 98.67 | −12.2% |
| Attributable to shareholders of the company | 80.81 | 69.96 | +15.5% | 93.27 | −13.4% |
| EPS, basic (₹) | 10.10 | 8.74 | +15.6% | 11.65 | −13.3% |
| Net margin (%) | 14.3 | 16.0 | 17.1 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 298.90 | 262.95 | +13.7% | 293.35 | +1.9% |
| Other income | 3.84 | 3.71 | +3.6% | 4.97 | −22.8% |
| Total income | 302.74 | 266.66 | +13.5% | 298.32 | +1.5% |
| Profit before tax | 83.98 | 70.02 | +19.9% | 97.97 | −14.3% |
| Net profit for the period | 62.63 | 52.12 | +20.2% | 74.70 | −16.1% |
| EPS, basic (₹) | 7.83 | 6.51 | +20.3% | 9.33 | −16.1% |
| Net margin (%) | 21.0 | 19.8 | 25.5 |
Consolidated
- Filed with BSE
- 07 Aug 2023, 18:27 IST
- Board meeting
- 07 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Aug 2023, 18:27 IST
- Board meeting
- 07 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE